A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
Bryan R. Haugen(University of Colorado Cancer Center), E. Chester Ridgway(Boston University), Kathryn E. Graham(Oregon Health & Science University), Gilbert H. Daniels(Harvard University), Markus Luster(Klinik und Poliklinik für Nuklearmedizin), Paul W. Ladenson(Johns Hopkins Medicine), Martin Schlumberger(Université Paris-Saclay), Kevin McEllin, Harry R. Maxon(University of Cincinnati), David S. Cooper(Johns Hopkins Medicine), Terry F. Davies(Icahn School of Medicine at Mount Sinai), Christoph Reiners(Klinik und Poliklinik für Nuklearmedizin), Lewis E. Braverman(Brigham and Women's Hospital), Carole A. Spencer(University of Southern California), D. Vaughn Becker(NewYork–Presbyterian Hospital), Furio Pacini, Steven I. Sherman(Johns Hopkins University), Ernest L. Mazzaferri(The Ohio State University), Leslie J. DeGroot(University of Chicago), Bruce D. Weintraub(University of Maryland, Baltimore), Monica C. Skarulis(National Institutes of Health), Mary H. Samuels(Oregon Health & Science University), Ralph R. Cavalieri(United States Department of Veterans Affairs), Douglas S. Ross(Massachusetts General Hospital)
Cited by 564
Related Papers
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
|Thyroid|2009|6.7k
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
|Thyroid|2016|2.8k
Subclinical Thyroid Disease
|JAMA|2004|1.8k
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|921